Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 28.10
-0.10 (-0.35%)
May 28, 2026, 1:17 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.38 billion as of May 28, 2026. Its market cap has decreased by -12.18% in one year.
Market Cap
2.38B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.10
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.38B, an increase of 23.32%. That is a compound annual growth rate of 5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 2.38B | -1.23% |
| Dec 31, 2025 | 2.41B | -31.88% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apex Biotechnology | 2.96B |
| Chunghwa Chemical Synthesis & Biotech | 2.92B |
| GlycoNex Incorporation | 2.91B |
| Intech Biopharm | 2.81B |
| HeXun Biosciences | 2.75B |
| Syngen Biotech | 2.64B |
| Sunhawk Vision Biotech | 2.60B |
| 3D Global Biotech | 2.38B |